Form 10|K for Sangamo Therapeutics INC filed 02/23/2023
Form 10-K for Sangamo Therapeutics INC filed 02/23/2023
☒. If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the ...
SEC Filings | Sangamo Therapeutics, Inc.
SEC Filings ; Apr 17, 2023, ARS. An annual report to security holders ; Feb 23, 2023, 10-K · Annual report which provides a comprehensive ...
SANGAMO THERAPEUTICS, INC - EDGAR Entity Landing Page
[+] 8-K (current reports) ... 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the ...
SEC Filings - Sangamo Therapeutics, Inc.
Filing date · Form · Description, Filing Group, View. Nov 12, 2024, 10-Q. Quarterly report which provides a continuing view of a ...
Form S-8 for Sangamo Therapeutics INC filed 02/23/2023
This Registration Statement on Form S-8 is being filed by Sangamo Therapeutics, Inc. ... 3.1 to the Registrant's Current Report on Form 8-K filed ...
SEC Filings | Sangamo Therapeutics, Inc.
Filing date · Form · Description, Filing Group, View. Dec 23, 2022, 8-K. Report of unscheduled material events or corporate event. Current Reports. PDF · DOC.
Form 10-Q for Sangamo Therapeutics INC filed 11/01/2023
... filed with the SEC on. February 23, 2023. The accompanying Condensed Consolidated Financial Statements include the accounts of the Company ...
0001628280-24-010788 | 10-K | Sangamo Therapeutics, Inc.
Annual report which provides a comprehensive overview of the company for the past year. Filing Group. Annual Filings. Company. Sangamo ...
Form 10-Q for Sangamo Therapeutics INC filed 08/08/2023
... Sangamo's Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Annual Report”) as filed with the SEC on February 23, 2023.
PFIZER INC (Form: 10-K, Received - EDGAR Online
... filed or to be filed with the SEC, including our Proxy Statement. ... (g)Being developed in collaboration with Sangamo Therapeutics, Inc.
Sangamo Therapeutics - Wikipedia
Sangamo Therapeutics, Inc is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and ...
SGMO Sangamo Therapeutics, Inc. Stock Price & Overview
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and ...
BlackRock Inc. ownership in SGMO / Sangamo Therapeutics, Inc.
2024-07-08 - BlackRock Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,702,938 shares of Sangamo ...
Form PRE 14A for AN2 Therapeutics INC filed 04/05/2024
... Sangamo Therapeutics, Inc., a publicly traded biotechnology company, and. Acceleron Pharma, a publicly traded biotechnology company. From December 2009 to ...
ZFP Therapeutic ® is a registered trademark of Sangamo BioSciences, Inc. ... Company's Form 10-K filed on February 16, 2011). 10.50†, Letter Agreement ...
ZA201802723B - Liver-specific constructs, factor viii expression ...
Application filed by Sangamo Therapeutics Inc. 2019-07-31. Publication of ... AU2016343887B2 2015-10-28 2023-04-06 Sangamo Therapeutics, Inc. Liver ...
Sangamo Therapeutics Inc (SGMO) Stock Price & News - Google
Get the latest Sangamo Therapeutics Inc (SGMO) real-time quote, historical performance, charts, and other financial information to help you make more ...
united states securities and exchange commission
See accompanying Notes to Condensed Consolidated Financial Statements. 6. Page 7. SANGAMO THERAPEUTICS, INC. CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' ...
PFE-2022-Form-10K-FINAL-(without-Exhibits).pdf
(g) Being developed in collaboration with Sangamo Therapeutics, Inc. ... Form 10-K filed with the Securities and Exchange Commission. Under ...
Corporate Partner News | World Federation of Hemophilia
FDA places the Pfizer/Sangamo Therapeutics phase 3 AFFINE haemophilia A gene therapy study on clinical hold ... SAN RAFAEL, U.S.A. – January 10, 2021 — BioMarin ...